Products for Research Use Only
RegisterLogin

Amubarvimab

CAT: 0804-HY-P99435-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99435-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Amubarvimab (BRII-196) is a human IgG1 mAb that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein, with a KD of 5.88 nM. Amubarvimab can effectively neutralize SARS-CoV-2 variants[1][2].
CAS Number
2509447-07-6
Product Name Alternative
BRII-196
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/amubarvimab.html
Purity
95.00
Solubility
H2O
Smiles
[Amubarvimab]
Molecular Weight
(143.84 kDa)
References & Citations
[1]Ji Y, et, al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Front Immunol. 2022 Sep 14;13:980435. |[2]Hoy SM. Amubarvimab/Romlusevimab: First Approval. Drug. 2022 Aug;82 (12) :1327-1331.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
T76904-01Amubarvimab
GTR18337869-01Amubarvimab Antibody
MBS1564024-01Research Grade Amubarvimab
E55B0859Amubarvimab (Reference antibody)
GTR18780143-01(Amubarvimab) Biosimilar Reference Antibody
048214Spike RBD (Amubarvimab) discontinued
ICH5342-10mgAmubarvimab Biosimilar - Research Grade
GTR18697274-01Amubarvimab Human Monoclonal Antibody
F1022-50Anti-Spike RBD Antibody (Amubarvimab)
GTR18315669Spike RBD Reference Antibody (Amubarvimab)

Popular Products